Supplement reference
NR (Nicotinamide Riboside)
A source-linked reference on NR (Nicotinamide Riboside), evidence, safety and product identity. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
Ingredient and preparation
Nicotinamide riboside is a nicotinamide-related compound sold in products that often reference NAD metabolism.
Sources: National Library of Medicine, PubMed
Evidence and limits
The cited review pooled human trials of NMN and NR in older adults and found muscle-function evidence inconclusive. Changes in NAD-related biomarkers do not by themselves establish a patient-important outcome.
Sources: National Library of Medicine, PubMed
Safety and a useful record
The safety and interaction discussion depends on the product, health history and other medicines. Do not generalise from laboratory or short-term findings.
Sources: National Library of Medicine, PubMed, National Center for Complementary and Integrative Health
Record the product identity, stated outcome and any relevant tests with their laboratory range.
Sources: National Center for Complementary and Integrative Health
Published sources
- The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis
National Library of Medicine, PubMed. Published 2025; accessed 6 September 2026.
Supports: Human NMN/NR trials in older adults; pooled evidence for muscle-function outcomes was inconclusive.
- Safe Use of Complementary Health Products and Practices
National Center for Complementary and Integrative Health. Current NCCIH reference; accessed 6 September 2026.
Supports: General safety, interaction and contamination context. It does not establish ingredient-specific benefit.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.